<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00513799</url>
  </required_header>
  <id_info>
    <org_study_id>9000C4</org_study_id>
    <nct_id>NCT00513799</nct_id>
  </id_info>
  <brief_title>The Natural History of Community-Associated MRSA Infections and Decolonization Strategies</brief_title>
  <acronym>StLStaRS</acronym>
  <official_title>The Natural History of Community-Associated Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections and an Evaluation of Decolonization Strategies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the natural history of community-associated
      Staphylococcus aureus infections in both adult and pediatric patients by monitoring the rate
      of recurrent infections in those colonized with S. aureus.

      In addition, this study will evaluate the efficiency of commonly prescribed decolonization
      measures in patients presenting with S. aureus skin and soft tissue infections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infections with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
      range in severity from superficial skin abscesses to invasive soft tissue infections like
      cellulitis and pyomyositis. There has been a large increase in the number of patients
      presenting to our institution with CA-MRSA infections. Colonization with S. aureus (SA) may
      be linked to the development of infection but data on this phenomenon are limited. The
      recurrence rate for CA-MRSA soft tissue infections is unknown. A variety of decolonization
      strategies have been used for infection prophylaxis with varying results, primarily in
      patients undergoing hemodialysis or surgery. This study seeks to determine the recurrence
      rate of soft tissue infections among patients with CA-MRSA infections and to determine a
      reasonable and efficacious decolonization strategy to eradicate CA-MRSA from previously
      infected patients.

      The proposed methods for decolonization will be tested in a randomized controlled trial with
      four intervention arms. The intervention arms are: (1) intensive education on prevention of
      skin infections through improvements in personal hygiene (also serves as &quot;control group&quot;),
      (2) application of mupirocin in the nasal mucosa alone, (3) a combination of nasal
      application of mupirocin and chlorhexidine showers, and (4) a combination of nasal
      application of mupirocin and bathing in dilute bleach water. The &quot;control&quot; group as well as
      the three other arms will receive intensive hygiene education.

      Decolonization with mupirocin ointment and chlorhexidine showers or dilute bleach baths in
      combination are likely to be more successful than either the application of nasal mupirocin
      ointment alone or hygiene measures alone. It is expected that these decolonization methods
      will result in a 50% relative reduction in MRSA colonization at 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Eradicated of S. Aureus Carriage - 1 Month After Intervention</measure>
    <time_frame>1 month follow-up</time_frame>
    <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient. Samples obtained by study team at follow-up visit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Recurrent Staphylococcus Aureus Skin or Soft Tissue Infection</measure>
    <time_frame>1, 4 and 6 month follow-ups</time_frame>
    <description>Recurrent Staphylococcus aureus Skin or Soft Tissue Infection is defined as incidence of skin abscess, impetigo, cellulitis, or spider bite in the 1 month following intervention. Infections reported by participant at follow-up visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Eradicated of S. Aureus Carriage - 4 Months After Intervention</measure>
    <time_frame>4 month follow-up</time_frame>
    <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient. Samples obtained by study team at follow-up visit.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Abscesses</condition>
  <condition>Furunculosis</condition>
  <condition>Staphylococcus Aureus</condition>
  <condition>Staphylococcal Skin Infections</condition>
  <arm_group>
    <arm_group_label>1: Hygiene Education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intensive education on prevention of skin infections through improvements in personal hygiene (also serves as &quot;control group&quot;)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2: Hygiene education + mupirocin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of mupirocin in the nasal mucosa alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Education + mupirocin + chlorhexidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A combination of nasal application of mupirocin and chlorhexidine showers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4: Education + mupirocin + bleach baths</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A combination of nasal application of mupirocin and bathing in dilute bleach water</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mupirocin ointment</intervention_name>
    <description>Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.</description>
    <arm_group_label>2: Hygiene education + mupirocin</arm_group_label>
    <arm_group_label>Education + mupirocin + chlorhexidine</arm_group_label>
    <arm_group_label>4: Education + mupirocin + bleach baths</arm_group_label>
    <other_name>Bactroban</other_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Chlorhexidine showers</intervention_name>
    <description>Apply Clorhexidine wash to entire body once daily for 5 days.</description>
    <arm_group_label>Education + mupirocin + chlorhexidine</arm_group_label>
    <other_name>Hibiclens</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bleach baths (dilute)</intervention_name>
    <description>Pour 2 ounces of bleach into water-filled bath tub. Soak in bath for 15 minutes. Apply once daily for 5 days.</description>
    <arm_group_label>4: Education + mupirocin + bleach baths</arm_group_label>
    <other_name>Clorox</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intensive education on personal hygiene</intervention_name>
    <description>Repeat hygiene methods for 5 days.</description>
    <arm_group_label>1: Hygiene Education</arm_group_label>
    <arm_group_label>2: Hygiene education + mupirocin</arm_group_label>
    <arm_group_label>Education + mupirocin + chlorhexidine</arm_group_label>
    <arm_group_label>4: Education + mupirocin + bleach baths</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient who presents with at least one serious skin or soft tissue infection
             requiring incision and drainage at an affiliated institution or clinic in the St.
             Louis metropolitan area

        Exclusion Criteria:

          -  Patients with permanent indwelling catheters or percutaneous medical devices

          -  Patients with a history of dialysis treatments, long term care facility admission, or
             presents with a surgical wound infection within the past year

          -  Patients who are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard C. Camins, MD, MSCR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor of Medicine, Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregory A. Storch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Medicine and Molecular Microbiology, Chief of Division of Pediatric Infectious Diseases, Department of Medicine, Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barnes-Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis Children's Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2007</study_first_submitted>
  <study_first_submitted_qc>August 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2007</study_first_posted>
  <results_first_submitted>March 2, 2011</results_first_submitted>
  <results_first_submitted_qc>March 2, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 29, 2011</results_first_posted>
  <last_update_submitted>July 7, 2015</last_update_submitted>
  <last_update_submitted_qc>July 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington University School of Medicine</investigator_affiliation>
    <investigator_full_name>Stephanie A. Fritz</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Skin Diseases, Infectious</mesh_term>
    <mesh_term>Staphylococcal Skin Infections</mesh_term>
    <mesh_term>Furunculosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Mupirocin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Hygiene Education</title>
          <description>Participants only administered an intensive education on prevention of skin infections through improvements in personal hygiene (also serves as &quot;control group&quot;)</description>
        </group>
        <group group_id="P2">
          <title>Hygiene Education + Mupirocin</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days</description>
        </group>
        <group group_id="P3">
          <title>Education + Mupirocin + Chlorhexidine</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed Chlorhexidine wash to entire body once daily for 5 days.</description>
        </group>
        <group group_id="P4">
          <title>Education + Mupirocin + Bleach Baths</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed bleach bath to entire body once daily for 5 days (instructed to pour 2 ounces of bleach into water-filled bath tub and soak in bath for 15 minutes).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>One-Month Follow-Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="75"/>
                <participants group_id="P4" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="62"/>
                <participants group_id="P3" count="64"/>
                <participants group_id="P4" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="21"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Four-Month Follow-Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="62"/>
                <participants group_id="P3" count="64"/>
                <participants group_id="P4" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="57"/>
                <participants group_id="P3" count="57"/>
                <participants group_id="P4" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hygiene Education</title>
          <description>Participants only administered an intensive education on prevention of skin infections through improvements in personal hygiene (also serves as &quot;control group&quot;)</description>
        </group>
        <group group_id="B2">
          <title>Hygiene Education + Mupirocin</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days</description>
        </group>
        <group group_id="B3">
          <title>Education + Mupirocin + Chlorhexidine</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed Chlorhexidine wash to entire body once daily for 5 days.</description>
        </group>
        <group group_id="B4">
          <title>Education + Mupirocin + Bleach Baths</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed bleach bath to entire body once daily for 5 days (instructed to pour 2 ounces of bleach into water-filled bath tub and soak in bath for 15 minutes).</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
            <count group_id="B2" value="75"/>
            <count group_id="B3" value="75"/>
            <count group_id="B4" value="75"/>
            <count group_id="B5" value="300"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.37" spread="16.57"/>
                    <measurement group_id="B2" value="16.52" spread="16.12"/>
                    <measurement group_id="B3" value="18.19" spread="17.37"/>
                    <measurement group_id="B4" value="18.67" spread="15.29"/>
                    <measurement group_id="B5" value="17.61" spread="16.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="52"/>
                    <measurement group_id="B4" value="38"/>
                    <measurement group_id="B5" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="37"/>
                    <measurement group_id="B5" value="139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Eradicated of S. Aureus Carriage - 1 Month After Intervention</title>
        <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient. Samples obtained by study team at follow-up visit.</description>
        <time_frame>1 month follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hygiene Education</title>
            <description>Participants only administered an intensive education on prevention of skin infections through improvements in personal hygiene (also serves as &quot;control group&quot;)</description>
          </group>
          <group group_id="O2">
            <title>Hygiene Education + Mupirocin</title>
            <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days</description>
          </group>
          <group group_id="O3">
            <title>Education + Mupirocin + Chlorhexidine</title>
            <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed Chlorhexidine wash to entire body once daily for 5 days.</description>
          </group>
          <group group_id="O4">
            <title>Education + Mupirocin + Bleach Baths</title>
            <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed bleach bath to entire body once daily for 5 days (instructed to pour 2 ounces of bleach into water-filled bath tub and soak in bath for 15 minutes).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Eradicated of S. Aureus Carriage - 1 Month After Intervention</title>
          <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient. Samples obtained by study team at follow-up visit.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="62"/>
                <count group_id="O3" value="64"/>
                <count group_id="O4" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="35"/>
                    <measurement group_id="O4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Recurrent Staphylococcus Aureus Skin or Soft Tissue Infection</title>
        <description>Recurrent Staphylococcus aureus Skin or Soft Tissue Infection is defined as incidence of skin abscess, impetigo, cellulitis, or spider bite in the 1 month following intervention. Infections reported by participant at follow-up visit.</description>
        <time_frame>1, 4 and 6 month follow-ups</time_frame>
        <population>Groups 1/4 have 1 more participant analyzed each than in participant flow module due to data collected by phone. They did not return to hospital for followup (colonization swabs were not obtained). Group 3 has 1 less participant analyzed than in participant flow module due to missing data point on followup survey. They were not able to be reached.</population>
        <group_list>
          <group group_id="O1">
            <title>1: Hygiene Education</title>
            <description>Intensive education on prevention of skin infections through improvements in personal hygiene (also serves as &quot;control group&quot;)
Intensive education on personal hygiene: Repeat hygiene methods for 5 days.</description>
          </group>
          <group group_id="O2">
            <title>2: Hygiene Education + Mupirocin</title>
            <description>Application of mupirocin in the nasal mucosa alone
Mupirocin ointment: Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Intensive education on personal hygiene: Repeat hygiene methods for 5 days.</description>
          </group>
          <group group_id="O3">
            <title>Education + Mupirocin + Chlorhexidine</title>
            <description>A combination of nasal application of mupirocin and chlorhexidine showers
Mupirocin ointment: Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Chlorhexidine showers: Apply Clorhexidine wash to entire body once daily for 5 days.
Intensive education on personal hygiene: Repeat hygiene methods for 5 days.</description>
          </group>
          <group group_id="O4">
            <title>4: Education + Mupirocin + Bleach Baths</title>
            <description>A combination of nasal application of mupirocin and bathing in dilute bleach water
Mupirocin ointment: Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Bleach baths (dilute): Pour 2 ounces of bleach into water-filled bath tub. Soak in bath for 15 minutes. Apply once daily for 5 days.
Intensive education on personal hygiene: Repeat hygiene methods for 5 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Recurrent Staphylococcus Aureus Skin or Soft Tissue Infection</title>
          <description>Recurrent Staphylococcus aureus Skin or Soft Tissue Infection is defined as incidence of skin abscess, impetigo, cellulitis, or spider bite in the 1 month following intervention. Infections reported by participant at follow-up visit.</description>
          <population>Groups 1/4 have 1 more participant analyzed each than in participant flow module due to data collected by phone. They did not return to hospital for followup (colonization swabs were not obtained). Group 3 has 1 less participant analyzed than in participant flow module due to missing data point on followup survey. They were not able to be reached.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="62"/>
                <count group_id="O3" value="63"/>
                <count group_id="O4" value="55"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 Month Follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 Month Follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Follow-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Eradicated of S. Aureus Carriage - 4 Months After Intervention</title>
        <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient. Samples obtained by study team at follow-up visit.</description>
        <time_frame>4 month follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>1: Hygiene Education</title>
            <description>Intensive education on prevention of skin infections through improvements in personal hygiene (also serves as &quot;control group&quot;)
Intensive education on personal hygiene: Repeat hygiene methods for 5 days.</description>
          </group>
          <group group_id="O2">
            <title>2: Hygiene Education + Mupirocin</title>
            <description>Application of mupirocin in the nasal mucosa alone
Mupirocin ointment: Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Intensive education on personal hygiene: Repeat hygiene methods for 5 days.</description>
          </group>
          <group group_id="O3">
            <title>Education + Mupirocin + Chlorhexidine</title>
            <description>A combination of nasal application of mupirocin and chlorhexidine showers
Mupirocin ointment: Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Chlorhexidine showers: Apply Clorhexidine wash to entire body once daily for 5 days.
Intensive education on personal hygiene: Repeat hygiene methods for 5 days.</description>
          </group>
          <group group_id="O4">
            <title>4: Education + Mupirocin + Bleach Baths</title>
            <description>A combination of nasal application of mupirocin and bathing in dilute bleach water
Mupirocin ointment: Add a small amount of Mupirocin to the cotton end of a swab. Swab in inner nostril, then repeat in other nostril using new cotton swab with ointment. Twice daily treatment for 5 days.
Bleach baths (dilute): Pour 2 ounces of bleach into water-filled bath tub. Soak in bath for 15 minutes. Apply once daily for 5 days.
Intensive education on personal hygiene: Repeat hygiene methods for 5 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Eradicated of S. Aureus Carriage - 4 Months After Intervention</title>
          <description>Eradication is defined as the absence of S. aureus carriage at the 3 sampled body sites (anterior nares, axilla, inguinal folds) of the index patient. Samples obtained by study team at follow-up visit.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="57"/>
                <count group_id="O3" value="57"/>
                <count group_id="O4" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected by phone approximately 7-10 days following study enrollment. The intervention only lasted 5 days and thus all adverse events would have happened by this time.</time_frame>
      <desc>There are more participants with data on adverse events than data on the primary outcome measure because some participants completed the follow-up phone call at 7-10 days (where adverse events were assessed) but failed to complete the 1 month follow-up visit (where primary outcome measure was assessed).</desc>
      <group_list>
        <group group_id="E1">
          <title>Hygiene Education</title>
          <description>Participants only administered an intensive education on prevention of skin infections through improvements in personal hygiene (also serves as &quot;control group&quot;)</description>
        </group>
        <group group_id="E2">
          <title>Hygiene Education + Mupirocin</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days</description>
        </group>
        <group group_id="E3">
          <title>Education + Mupirocin + Chlorhexidine</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed Chlorhexidine wash to entire body once daily for 5 days.</description>
        </group>
        <group group_id="E4">
          <title>Education + Mupirocin + Bleach Baths</title>
          <description>Participants administered an intensive education on prevention of skin infections through improvements in personal hygiene AND prescribed Mupirocin ointment applied to the nasal mucosa twice daily for 5 days AND prescribed bleach bath to entire body once daily for 5 days (instructed to pour 2 ounces of bleach into water-filled bath tub and soak in bath for 15 minutes).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="70"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="70"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="72"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="70"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Stephanie Fritz</name_or_title>
      <organization>Washington University</organization>
      <phone>314-454-6050</phone>
      <email>fritz_s@kids.wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

